Himax Technologies, Inc. to Attend Susquehanna 12th Annual
TAINAN, Taiwan, Feb. 17, 2023 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a
Globe Newswire17-02-2023, 15:41
Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00